ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
- EBITDA, 2025
- −$122M
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | −$122M | — |
| 2023 | −$7.3M | — |
| 2022 | −$11M | — |
| 2021 | −$19M | — |
| 2020 | −$9.8M | — |
| 2019 | −$5.8M | — |
| 2018 | −$8.1M | — |
| 2017 | −$19M | — |
| 2016 | −$17M | — |
| 2015 | −$11M | — |
| 2014 | −$9.7M | — |
| 2013 | −$6.9M | — |
| 2012 | −$4.3M | — |
| 2011 | −$6.8M | — |
| 2010 | −$8.8M | — |